Today's special offer: Access for Free!!!

Sanofi (SNY) | Income Statement

See also

ˇ Show More

The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Sanofi, Consolidated Income Statement

USD $ in millions, translated from EUR €

Export to Excel Export to OpenOffice.org
  12 months ended Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
chart Net sales
chart Other revenues
chart Cost of sales
chart Gross profit
chart Research and development expenses
chart Selling and general expenses
chart Other operating income
chart Other operating expenses
chart Amortization of intangible assets
chart Impairment of intangible assets
chart Fair value remeasurement of contingent consideration liabilities
chart Restructuring costs
chart Other gains and losses, and litigation
chart Operating income
chart Cost of debt
chart Interest income
chart Cost of debt, net of cash and cash equivalents
chart Non-operating foreign exchange gains (losses)
chart Fair value gains (losses) on other derivatives
chart Unwinding of discount on provisions
chart Gains (losses) on disposals of financial assets
chart Impairment losses on financial assets, net of reversals
chart Other items
chart Net financial income (expenses)
chart Income before tax and associates and joint ventures
chart Income tax expense
chart Share of profit (loss) of associates and joint ventures
chart Net income excluding the held-for-exchange Merial business
chart Net income from the held-for-exchange Merial business
chart Net income
chart Net income attributable to non-controlling interests
chart Net income attributable to equity holders of Sanofi
Source: Sanofi, Annual Reports
Item Description The company
Net sales Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Sanofi's net sales declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level.
Operating income The net result for the period of deducting operating expenses from operating revenues. Sanofi's operating income declined from 2009 to 2010 and from 2010 to 2011.
Income before tax and associates and joint ventures Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Sanofi's income before tax and associates and joint ventures declined from 2009 to 2010 and from 2010 to 2011.
Net income excluding the held-for-exchange Merial business This represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Sanofi's net income excluding the held-for-exchange Merial business declined from 2009 to 2010 but then increased from 2010 to 2011 not reaching 2009 level.
Net income The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Sanofi's net income declined from 2009 to 2010 but then slightly increased from 2010 to 2011.
Net income attributable to equity holders of Sanofi The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Sanofi's net income attributable to equity holders of Sanofi declined from 2009 to 2010 but then slightly increased from 2010 to 2011.

Top

Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center